Citius Pharmaceuticals, Inc. Debt Related Commitment Fees and Debt Issuance Costs
Citius Pharmaceuticals, Inc. (CTXR) reported Debt Related Commitment Fees and Debt Issuance Costs of -$42.00 thousand for the 12-month period ending 2013-12-31, per its 10-KT filed 2014-12-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts · last filed 2014-12-29
- Citius Pharmaceuticals, Inc. debt related commitment fees and debt issuance costs for fiscal 2013 was -$42.00K.
| Period end | Debt Related Commitment Fees and Debt Issuance Costs 12 month |
|---|---|
| 2013-12-31 | -$42.00K 10-KT · filed 2014-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |